People: AEterna Zentaris Inc (AEZS.O)
2.10USD
17 May 2013
$0.04 (+1.94%)
$2.06
$2.09
$2.15
$2.06
224,282
342,896
$5.63
$1.70
Egbert, Carolyn
Brief Biography
Ms. Carolyn Egbert has been appointed as Director of Aeterna Zentaris Inc with effect from August 14, 2012. Her appointment is based on her experience in pharmacology, human resources and corporate governance with a focus on organizational design and global restructuring. She was also a on the Board of Directors of Solvay North America and its subsidiaries Peptisyntha and Solvay Enzymes.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Juergen Ernst |
897,704 |
David Dodd |
-- |
Dennis Turpin |
549,197 |
Paul Blake |
607,515 |
Nicholas Pelliccione |
539,979 |
Matthias Seeber |
613,872 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
